Australia
Bangladesh
Belgium
Brazil
Canada
China
Egypt
France
Germany
India
Indonesia
Ireland
VAQORALevothyroxine Impurity D (Stage-1)
Synonyms: 4-Hydroxy-3,5-dinitrobenzeneacetic acid · 3,5-Dinitro-4-hydroxybenzeneacetic acid · 3,5-Dinitro-4-hydroxyphenylacetic acid · 4-Hydroxy-3,5-dinitrophenylacetic acid
CAS No.10463-37-3
FormulaC8H6N2O7
Mol. weight242.14
Catalogue No.VQ-005187
PurityReference Standard
HSN38229090
Levothyroxine Impurity D (Stage-1) (CAS 10463-37-3) – Levothyroxine impurity standard. C8H6N2O7, MW 242.14. Vaqora Chemicals: COA, global shipping.
Pack sizesPrice on quotation · bulk available
10 mg
25 mg
50 mg
100 mg
250 mg
Bulk / custom pack · kg to MT
Enquire Batch COA with every lot
16-section GHS SDS
Export to 120+ countries
DG-compliant packing
About Levothyroxine Impurity D (Stage-1)
Listed under CAS 10463-37-3, Levothyroxine Impurity D (Stage-1) is an impurity of Levothyroxine available from Vaqora Chemicals. Its molecular formula is C8H6N2O7 and its molecular weight is 242.14 g/mol. Systematically, it is named 2-(4-hydroxy-3,5-dinitrophenyl)acetic acid. Common synonyms include 4-Hydroxy-3,5-dinitrobenzeneacetic acid and 3,5-Dinitro-4-hydroxybenzeneacetic acid.
It is supplied as a solid. Reference materials should be stored sealed and away from light and moisture, as specified on the accompanying COA. The GHS classification uses the signal word “Warning”, so appropriate gloves, eye protection and ventilation are recommended.
Pharmaceutical QC and development laboratories use this impurity standard of Levothyroxine to develop and validate HPLC methods, to set specification limits and to document impurity profiles in ANDA and DMF submissions. Our customers for this product work in pharmaceutical manufacturing and academic and industrial research.
Vaqora Chemicals supplies Levothyroxine Impurity D (Stage-1) in 10 mg, 25 mg, 50 mg and 100 mg packs, each shipped with a Certificate of Analysis (COA), and exports worldwide. Stock is available for quick dispatch.
Typical applications
- Analytical method development
- Method validation (AMV)
- QC release testing
- ANDA / DMF filings
Industries
Related to Levothyroxine
View every impurity, metabolite and intermediate we list for Levothyroxine.
Levothyroxine impuritiesSpecifications & identifiers
| Product name | Levothyroxine Impurity D (Stage-1) |
|---|---|
| Catalogue No. | VQ-005187 |
| CAS Number | 10463-37-3 |
| IUPAC name | 2-(4-hydroxy-3,5-dinitrophenyl)acetic acid |
| Molecular formula | C8H6N2O7 |
| Molecular weight | 242.14 g/mol |
| Exact mass | 242.0175 |
| Grade | Reference Standard |
| HSN code | 38229090 |
| InChIKey | MLVYQQLUGFSXQH-UHFFFAOYSA-N |
| SMILES | C1=C(C=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])CC(=O)O |
| PubChem CID | 98596 |
| Physical form | Solid |
|---|---|
| LogP (XLogP3) | 1.2 |
| H-bond donors / acceptors | 2 / 7 |
| TPSA | 149 Ų |
| Synonyms | 4-Hydroxy-3,5-dinitrobenzeneacetic acid, 3,5-Dinitro-4-hydroxybenzeneacetic acid, 3,5-Dinitro-4-hydroxyphenylacetic acid, 4-Hydroxy-3,5-dinitrophenylacetic acid, Levothyroxine Impurity D (Stage-1 ), 3,5-Dinitro-4-hydroxyphenacetic acid, 4-Hydroxy-3,5-dinitrophenacetyl, (4-Hydroxy-3,5-dinitrophenyl)acetic acid, (4-hydroxy-3,5-dinitro-phenyl)-acetic acid, Benzeneacetic acid, 4-hydroxy-3,5-dinitro-, 2-(4-hydroxy-3,5-dinitro-phenyl)acetic acid, 3,5-Dinitro-4-hydroxyphenyl-acetic acid |
Safety & hazard information (GHS)
Signal word: Warning
Hazard statements
H315Causes skin irritationH319Causes serious eye irritationH335May cause respiratory irritation
Precautionary statements: P261, P264, P264 + P265, P271, P280, P302 + P352, P304 + P340, P305 + P351 + P338, P319, P321, P332 + P317, P337 + P317, P362 + P364, P403 + P233, P405, P501
Classification is indicative (aggregated GHS notifications) and may vary by grade and concentration. Always refer to the SDS supplied with your lot.
Documents
Frequently asked questions
What is the CAS number of Levothyroxine Impurity D (Stage-1)?
The CAS Registry Number of Levothyroxine Impurity D (Stage-1) is 10463-37-3. It is also known as 4-Hydroxy-3,5-dinitrobenzeneacetic acid, 3,5-Dinitro-4-hydroxybenzeneacetic acid, 3,5-Dinitro-4-hydroxyphenylacetic acid.
What is the molecular formula and molecular weight of Levothyroxine Impurity D (Stage-1)?
Levothyroxine Impurity D (Stage-1) has the molecular formula C8H6N2O7 and a molecular weight of 242.14 g/mol. Its IUPAC name is 2-(4-hydroxy-3,5-dinitrophenyl)acetic acid.
What is Levothyroxine Impurity D (Stage-1) used for?
Levothyroxine Impurity D (Stage-1) is supplied as a characterised reference material related to Levothyroxine. It is used for analytical method development and validation (AMV), impurity profiling, stability studies and quality control, and in ANDA/DMF regulatory filings.
Which grade and pack sizes of Levothyroxine Impurity D (Stage-1) can I order?
We supply Levothyroxine Impurity D (Stage-1) in Reference Standard grade, in 10 mg, 25 mg, 50 mg, 100 mg, 250 mg packs. Larger bulk quantities and custom packing are quoted on request.
Do you provide a COA and SDS with Levothyroxine Impurity D (Stage-1)?
Yes. Every lot of Levothyroxine Impurity D (Stage-1) is shipped with a batch-specific Certificate of Analysis, and a 16-section GHS Safety Data Sheet is provided with the quotation and the shipment.
Can Levothyroxine Impurity D (Stage-1) be shipped internationally?
Yes. Levothyroxine Impurity D (Stage-1) is classified as hazardous, so it is packed in UN-approved packaging and shipped as dangerous goods under IATA/IMDG rules. We export worldwide on EXW, FOB, CIF and DAP terms.
Enquire about Levothyroxine Impurity D (Stage-1)
We reply within one business day with price, pack options, lead time and documentation.
Related products
